[HTML][HTML] PI3K signaling in normal B cells and chronic lymphocytic leukemia (CLL)

K Okkenhaug, JA Burger - B Cell Receptor Signaling, 2016 - Springer
B Cell Receptor Signaling, 2016Springer
B cells provide immunity to extracellular pathogens by secreting a diverse repertoire of
antibodies with high affinity and specificity for exposed antigens. The B cell receptor (BCR)
is a transmembrane antibody, which facilitates the clonal selection of B cells producing
secreted antibodies of the same specificity. The diverse antibody repertoire is generated by
V (D) J recombination of heavy and light chain genes, whereas affinity maturation is
mediated by activation-induced cytidine deaminase (AID)-mediated mutagenesis. These …
Abstract
B cells provide immunity to extracellular pathogens by secreting a diverse repertoire of antibodies with high affinity and specificity for exposed antigens. The B cell receptor (BCR) is a transmembrane antibody, which facilitates the clonal selection of B cells producing secreted antibodies of the same specificity. The diverse antibody repertoire is generated by V(D)J recombination of heavy and light chain genes, whereas affinity maturation is mediated by activation-induced cytidine deaminase (AID)-mediated mutagenesis. These processes, which are essential for the generation of adaptive humoral immunity, also render B cells susceptible to chromosomal rearrangements and point mutations that in some cases lead to cancer. In this chapter, we will review the central role of PI3Ks in mediating signals from the B cell receptor that not only facilitate the development of functional B cell repertoire, but also support the growth and survival of neoplastic B cells, focusing on chronic lymphocytic leukemia (CLL) B cells. Perhaps because of the central role played by PI3K in BCR signaling, B cell leukemia and lymphomas are the first diseases for which a PI3K inhibitor has been approved for clinical use.
Springer